FDA
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces 2024 Annual Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

